CSVAX Fees and Costs — Columbia International Dividend Income Fund, Class A
Data updated: 2026-07-29
The net expense ratio is 1.20%: a 0.76% management fee, a 0.25% 12b-1 fee plus 0.27% other expenses, less a 0.08% fee waiver. This share class carries a maximum front-end sales load of 5.75% and a deferred sales charge of up to 1.00%. In fiscal 2024 the fund paid $243K in broker commissions, 0.0441% of average net assets, and portfolio turnover was 31%.
CSVAX Fees and Expenses
Annual operating expenses and sales charges of CSVAX. Prospectus, as of August 31, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.76% |
| 12b-1 fee | 0.25% |
| Other expenses | 0.27% |
| Gross expense ratio | 1.28% |
| Fee waiver | −0.08% |
| Net expense ratio | 1.20% |
| Sales charges | |
|---|---|
| Max front load | 5.75% |
| Max deferred load | 1.00% |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | No |
CSVAX Costs Over Time
On $10,000 invested in CSVAX, assuming 5% a year before costs, total costs come to $1,464 over 5 years, cutting the return by 2.53% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Sales charges | $673 | $575 | $575 |
| Fund expenses (net expense ratio 1.20%) | $119 | $370 | $639 |
| Trading costs (broker commissions) | $4 | $14 | $23 |
| Lost growth on money paid in costs | $29 | $110 | $226 |
| Total costs | $825 | $1,068 | $1,464 |
| Value after costs | $9,675 | $10,508 | $11,299 |
| Impact on return, per year | 8.25% | 3.33% | 2.53% |
CSVAX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending August 31, 2024.
- Explicit cost rate (commissions ÷ average net assets): 0.0441%
- Total broker commissions: $243K
- Bought from dealers (principal trades, not a cost): —
- Portfolio turnover (prospectus): 31%
- Securities lending: none during the year
CSVAX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| Citi | $25K | 15.19% |
| UBS | $21K | 12.57% |
| Jefferies LLC | $20K | 11.96% |
| SMBC Nikko Securities America Inc. | $18K | 10.65% |
| Morgan Stanley International | $16K | 9.80% |
| Mizuho | $16K | 9.39% |
| Instinet LLC | $15K | 8.96% |
| Cowen Execution Services Limited | $15K | 8.71% |
| Joh. Berenberg, Gossler & Co. KG | $11K | 6.39% |
| JPMorgan | $11K | 6.37% |
Columbia International Dividend Income Fund Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| CLSYX | Institutional 3 Class | 0.77% | none |
| CADPX | Institutional 2 Class | 0.82% | none |
| CSVEX | C000253717 | 0.95% | none |
| CSVFX | Institutional Class | 0.95% | none |
| CSVAX | Class A | 1.20% | 5.75% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.